Mandate

Vinge advises Irisity in connection with new issues

November 07, 2017 Capital Markets and Public M&A

Vinge is advising Irisity AB (publ), listed on Nasdaq First North, in connection with a rights issue and a directed new issue of shares.

The rights issue is underwritten to 100% through subscription undertakings and underwriting guarantees. The directed issue occurs via Vätterledens Invest and Hans Andersson & Co AB, both long term strategic investors. An extraordinary general meeting will adopt a resolution concerning the issues on 24 November and a prospectus is expected to be published on 5 December with the subscription period commencing on 7 December. Irisity conducts operations within intelligent camera surveillance and develops camera solutions with the help of proactive working and self learning algorithms.

Vinge’s team consists of Anders Strid, Frida Bäckegren, Joel Zetterström (IP) and corporate assistant Camilla Andersson.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025